A Phase 2a, parallel-group, placebo-controlled, double-blind study of the effect of IXT-m200 on methamphetamine pharmacokinetics and subjective effects in methamphetamine users

Trial Profile

A Phase 2a, parallel-group, placebo-controlled, double-blind study of the effect of IXT-m200 on methamphetamine pharmacokinetics and subjective effects in methamphetamine users

Planning
Phase of Trial: Phase II

Latest Information Update: 11 Oct 2017

At a glance

  • Drugs Ch-mAb7F9 (Primary)
  • Indications Drug abuse
  • Focus Pharmacokinetics; Therapeutic Use
  • Acronyms STAMPOUT
  • Most Recent Events

    • 11 Oct 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top